A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant

By Heineman T.C.   Clements-Mann M.L.   Poland G.A.   Jacobson R.M.   Izu A.E.   Sakamoto D.   Eiden J.   Van Nest G.A.   Hsu H.H.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2769-2778

Elsevier

Access to resources Recommend Favorite

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

By West D.J.   Calandra G.B.  

Vaccine, Vol. 14, Iss. 11, 1996-08 ,pp. : 1019-1027

Elsevier

Access to resources Recommend Favorite

Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose

By Wistrom J.   Ahlm C.   Lundberg S.   Settergren B.   Arne Tarnvik  

Vaccine, Vol. 17, Iss. 17, 1999-04 ,pp. : 2162-2165

Elsevier

Access to resources Recommend Favorite

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

By Van Herck K.   Van Damme P.   Thoelen S.   Meheus A.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1933-1935

Elsevier

Access to resources Recommend Favorite

Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid

By Wild J.   Gruner B.   Metzger K.   Kuhrober A.   Pudollek H.-P.   Hauser H.   Schirmbeck R.   Reimann J.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 353-360

Elsevier

Access to resources Recommend Favorite